GO:0086065 cell communication involved in cardiac conduction: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0086065 describes any process that mediates interactions between a cell and its surroundings that contributes to cardiac conduction, including cell-cell signaling and cell-matrix attachment.
Gap junctions, especially those built from connexins such as GJA1 (connexin 43), are the principal effectors of electrical cell communication in the heart.
Disruption of cardiac cell communication is linked to heart failure, arrhythmia, dilated cardiomyopathy and hypertrophic cardiomyopathy.
Extracellular vesicles and their cargo are emerging as additional mediators of cardiac cell communication.
Single-cell and single-nucleus RNA-seq have revealed non-cardiomyocyte populations that participate in cardiac conduction-related communication.
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of genes acting in GO:0086065.

Description

GO:0086065, cell communication involved in cardiac conduction, is a biological process term that captures every interaction between a cardiac cell and its surroundings that contributes to the orderly spread of electrical excitation through the heart. The heart depends on rapid, directional transfer of ionic current from cell to cell, and this transfer is mediated by specialized structures such as gap junctions, adhesion complexes and the extracellular environment. Because conduction failure produces arrhythmia and pump failure, the genes and pathways annotated to this term are of direct clinical interest. The term is deliberately broad: it includes signaling between one cell and another, between a cell and the extracellular matrix, and between a cell and any other aspect of its environment. This breadth makes GO:0086065 a useful entry point for researchers who want to move from a list of conduction-related genes to a mechanistic, testable model. Recent single-cell and spatial studies have shown that conduction is not a cardiomyocyte-only phenomenon; fibroblasts, endothelial cells, immune cells and extracellular vesicles all contribute to the communication network that sustains cardiac rhythm. Understanding GO:0086065 therefore requires integrating electrophysiology, cell biology and multi-omic data.

cell communication involved in cardiac conduction At A Glance

GO ID GO:0086065
GO term cell communication involved in cardiac conduction
Ontology biological_process
Synonym none listed
Major function Mediates cell-cell, cell-matrix and cell-environment interactions that contribute to cardiac conduction
Key effectors Connexins and gap junction channels, adhesion proteins, extracellular vesicles
Related cell types Cardiomyocytes, cardiac fibroblasts, endothelial cells, immune cells
Disease relevance Heart failure, arrhythmia, dilated and hypertrophic cardiomyopathy
Research methods Patch clamp, dye transfer, single-cell RNA-seq, spatial transcriptomics, EV profiling

What Is GO:0086065?

In practical terms, GO:0086065 is the set of processes by which a cardiac cell exchanges information with its environment in a way that supports cardiac conduction. The QuickGO definition states that it is any process that mediates interactions between a cell and its surroundings that contributes to the process of cardiac conduction, encompassing signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment. The term has no synonyms in the current release. It sits under biological_process and is distinct from the broader term cardiac conduction itself, because it focuses specifically on the communicative events rather than on the resulting electrical wave.

Why Is cell communication involved in cardiac conduction Important in Cell Biology?

GO:0086065 matters because the heart is an electrically coupled syncytium: without reliable communication between cells, the coordinated contraction that sustains circulation breaks down. The global burden of cardiovascular risk factors remains enormous, and conduction-related phenotypes are a major contributor to morbidity and mortality. At the same time, new work shows that communication in the heart is not limited to gap junctions; extracellular vesicles and their cargo can modify recipient cell behavior and protect or harm the myocardium. Annotating genes to GO:0086065 therefore helps researchers prioritize candidates that act at the interface between a cell and its environment, which is exactly where many therapeutic opportunities lie.
Cardiac conduction depends on continuous cell-to-cell communication, so GO:0086065 is central to normal rhythm.
Gap junction remodeling is a well-recognized substrate for arrhythmia and heart failure.
Extracellular vesicles released by cardiac cells can carry signals that alter conduction and remodeling.
Non-cardiomyocyte populations contribute to conduction-related communication and are now resolvable by single-cell methods.
Dilated cardiomyopathy shows non-cardiomyocyte heterogeneity relevant to cell communication.
Hypertrophic cardiomyopathy involves lineage-specific regulatory changes that affect intercellular signaling.
Cardiovascular risk factors remain leading contributors to global disease burden, underscoring the need for mechanistic models.
CRISPR-based perturbation of communication genes enables causal rather than correlative inference.
Spatial transcriptomics can localize communication events within tissue architecture.
EV-focused pharmacology, such as tipifarnib, can modulate communication and protect from heart failure.

What Happens During cell communication involved in cardiac conduction?

Electrical coupling through gap junctions
In simple terms: Heart muscle cells are wired together by tiny channels so that an electrical signal can pass directly from one cell to the next.
The dominant mechanism of cell communication in cardiac conduction is direct ionic current flow through gap junction channels, which are composed of connexin proteins and permit rapid, low-resistance transfer of ions and small molecules between adjacent cells. This electrical coupling ensures that excitation spreads in a coordinated manner and that the heart contracts as a functional unit. Gap junction channels are dynamic structures whose number, localization and phosphorylation state determine conduction velocity and safety factor.
Cell-matrix and cell-cell attachment
In simple terms: Cells also need to stick to each other and to the surrounding scaffold so that the electrical connections stay in the right place.
GO:0086065 explicitly encompasses attachment between a cell and another cell or between a cell and the extracellular matrix, because mechanical coupling organizes the intercalated disc and positions gap junctions for effective conduction. Adhesion complexes at the intercalated disc integrate mechanical and electrical coupling, and disruption of this architecture impairs conduction.
Extracellular vesicle-mediated signaling
In simple terms: Cells can also send messages by releasing tiny packages that travel to other cells.
Extracellular vesicles, including large organelle-rich blebbisomes, are recognized mediators of intercellular communication that can transfer proteins, lipids and nucleic acids to recipient cells. In the heart, vesicle release can be pharmacologically modulated, and reducing extracellular vesicles with tipifarnib protects from heart failure, indicating that vesicle-mediated communication is functionally relevant to cardiac remodeling and conduction.
Non-cardiomyocyte participation
In simple terms: Other cell types in the heart, not just muscle cells, take part in the conversation.
Single-cell and single-nucleus RNA-seq studies have revealed heterogeneous non-cardiomyocyte populations, including fibroblasts, endothelial cells and immune cells, that participate in signaling networks relevant to cardiac conduction and remodeling. In dilated cardiomyopathy, comprehensive scRNA-seq and bulk RNA-seq analyses identified non-cardiomyocyte heterogeneity and novel cell populations that may influence conduction-related communication. In hypertrophic cardiomyopathy, lineage-specific regulatory changes were resolved by single-nucleus RNA-seq and spatial transcriptomics, linking specific cell lineages to altered intercellular signaling.
Integration with systemic risk and metabolic signaling
In simple terms: What happens elsewhere in the body, such as metabolic stress, can change how heart cells talk to each other.
Systemic risk factors contribute substantially to cardiovascular disease burden and can influence the myocardial environment in which cell communication occurs. Single-cell analyses in atherosclerosis have demonstrated cell-type-specific functional roles of RNA m6A modification, illustrating how epitranscriptomic regulation shapes communication between vascular and cardiac cell types. These findings place GO:0086065 within a broader physiological context in which metabolic and inflammatory signals modify conduction-relevant communication.

Key Genes Involved in GO:0086065 cell communication involved in cardiac conduction

The genes below encode proteins that execute or regulate cell communication involved in cardiac conduction, spanning gap junction channels, adhesion molecules, vesicle machinery and signaling effectors.
GeneMajor RoleResearch Relevance
GJA1Connexin 43 gap junction channel subunit enabling direct cell-cell ionic couplingCore effector of electrical communication; knockout and point-mutation models test conduction
GJA5Connexin 40 subunit enriched in fast-conducting tissueDetermines conduction velocity in atrial and Purkinje networks
GJC1Connexin 45 subunit contributing to gap junction diversityModulates coupling in specific cardiac compartments
GJD3Connexin 30.2 subunit in gap junction channelsCandidate for specialized conduction properties
CDH2N-cadherin mediating cell-cell adhesion at intercalated discsLinks mechanical adhesion to electrical coupling
DSPDesmoplakin in desmosomes and intercalated discAdhesion-related communication; disease models of cardiomyopathy
PKP2Plakophilin-2 in desmosomesIntercalated disc integrity and conduction-relevant adhesion
JUPPlakoglobin in desmosomes and adherens junctionsAdhesion-communication coupling
SCN5AVoltage-gated sodium channel generating excitatory currentUpstream of communication; determines excitability
GJA1 phosphorylation regulatorsKinases and phosphatases controlling connexin gating and turnoverRegulation of gap junction communication
RAB family GTPasesVesicle trafficking and extracellular vesicle releaseModulate EV-mediated communication
ESCRT componentsExtracellular vesicle biogenesisMechanistic dissection of vesicle communication
CD9Tetraspanin marker of extracellular vesiclesEV isolation and functional studies
CD63Tetraspanin marker of extracellular vesiclesEV characterization and tracking
CD81Tetraspanin marker of extracellular vesiclesEV profiling in cardiac models
METTL3RNA m6A writer influencing cell-type-specific signalingEpitranscriptomic control of communication
Non-cardiomyocyte markersFibroblast, endothelial and immune identity genesMap communication networks in cardiomyopathy

How Is cell communication involved in cardiac conduction Regulated?

Communication involved in cardiac conduction is regulated at multiple levels. Connexin trafficking, phosphorylation and turnover control the number and conductance of gap junction channels at the membrane, and these steps determine conduction velocity. Extracellular vesicle release is a regulated process that can be pharmacologically reduced, as shown by tipifarnib treatment that lowers extracellular vesicles and protects from heart failure. Epitranscriptomic modification, including RNA m6A, can act in a cell-type-specific manner to shape signaling programs relevant to cardiovascular communication. In disease states such as dilated and hypertrophic cardiomyopathy, lineage-specific regulatory changes alter the communication landscape, as revealed by single-cell and spatial transcriptomic analyses.

cell communication involved in cardiac conduction and Human Disease

GeneDisease / BiologyPotential Experimental Model
GJA1Arrhythmia and heart failure from gap junction remodelingKnockout and point-mutation cardiomyocyte lines
SCN5AConduction disease and arrhythmiaKnock-in of patient variants
PKP2Arrhythmogenic cardiomyopathy with intercalated disc defectsKnockout and tagged knock-in models
DSPCardiomyopathy with desmosomal disruptionPoint-mutation and knockout models
EV cargo genesHeart failure and remodelingOverexpression and vesicle-tracking models
Heart failure and arrhythmia
Loss or remodeling of gap junction communication impairs conduction and contributes to arrhythmogenesis and pump failure. Extracellular vesicle-mediated communication is also implicated, because reducing extracellular vesicles with tipifarnib protects from heart failure in experimental models.
Dilated cardiomyopathy
Comprehensive scRNA-seq and bulk RNA-seq analyses of dilated cardiomyopathy revealed non-cardiomyocyte heterogeneity and novel cell populations, indicating that altered communication among multiple cell types accompanies the disease.
Hypertrophic cardiomyopathy
Single-nucleus RNA-seq combined with spatial transcriptomics uncovered lineage-specific regulatory changes in hypertrophic cardiomyopathy, linking specific cell lineages to altered intercellular signaling and conduction-relevant remodeling.
Atherosclerosis and systemic risk
Atherosclerosis single-cell studies showed cell-type-specific functional roles of RNA m6A modification, illustrating how epitranscriptomic regulation of communication pathways contributes to vascular disease that indirectly affects cardiac conduction. Global risk factor analyses continue to show the large burden attributable to cardiovascular risk factors.

From cell communication involved in cardiac conduction-Related Genes to Experimental Models

Research QuestionSuitable Model
Is a connexin gene required for electrical coupling?CRISPR knockout in cardiomyocyte lines
Does a patient variant alter channel function?Point-mutation knock-in
Where does a communication protein localize?Tagged knock-in with fluorescent tag
Does increased expression enhance communication?Overexpression model
Which non-cardiomyocyte populations participate?Single-cell and single-nucleus RNA-seq
Are extracellular vesicles functionally relevant?EV profiling with pharmacological modulation

How to Study the cell communication involved in cardiac conduction Process

MethodWhat It MeasuresTypical Application
Patch clampIonic currents and electrical couplingFunctional conduction assays
Dye transferGap junction permeabilityCell-cell communication quantification
scRNA-seqCell-type-specific gene expressionMapping communication networks
snRNA-seqNuclear expression in tissueLineage-specific regulation
Spatial transcriptomicsGene expression with tissue locationLocalizing communication events
EV isolation and profilingVesicle number and cargoVesicle-mediated communication
m6A mappingRNA modification landscapeEpitranscriptomic regulation
Electrophysiology and dye transfer
Patch clamp and dye-coupling assays directly measure the functional consequence of gap junction communication between cardiac cells, providing the gold-standard readout for GO:0086065.
Single-cell and spatial transcriptomics
scRNA-seq, single-nucleus RNA-seq and spatial transcriptomics resolve which cell types express communication genes and where they sit within tissue architecture, as demonstrated in dilated and hypertrophic cardiomyopathy studies.
Extracellular vesicle analysis
Isolation and characterization of extracellular vesicles, including large blebbisomes, allows researchers to quantify vesicle-mediated communication and test pharmacological modulation.
Epitranscriptomic profiling
Mapping RNA m6A modification at single-cell resolution reveals cell-type-specific regulatory layers that shape communication programs in cardiovascular tissue.

How CRISPR Can Be Used to Study GO:0086065 cell communication involved in cardiac conduction

Knockout

CRISPR knockout of connexin and adhesion genes in cardiomyocyte models removes the protein of interest and tests whether it is required for electrical or mechanical communication, providing causal evidence for annotation to GO:0086065.

Point Mutation

Point-mutation models introduce disease-associated variants into communication genes, allowing researchers to separate loss-of-function, gain-of-function and dominant-negative effects on conduction.

Knock-in

Tagged knock-in of communication proteins enables live imaging of gap junction dynamics and vesicle trafficking without altering endogenous regulation.

Overexpression

Overexpression of communication genes or vesicle cargo tests sufficiency and can reveal protective or deleterious effects on cardiac remodeling, as illustrated by modulation of extracellular vesicles in heart failure models.

How EDITGENE Supports cell communication involved in cardiac conduction Research

Researchers studying cell communication involved in cardiac conduction-related genes often need to determine whether a candidate gene is causally involved in electrical or mechanical coupling, rather than merely correlated with disease. EDITGENE provides the CRISPR tools and cell models required to move from association to mechanism across knockout, point-mutation, knock-in, overexpression and library-screening workflows.
Contact EDITGENE today to design your custom CRISPR model for cell communication involved in cardiac conduction research.

Frequently Asked Questions About cell communication involved in cardiac conduction

It is a biological process term describing any process that mediates interactions between a cell and its surroundings that contributes to cardiac conduction, including cell-cell signaling, cell-matrix attachment and cell-environment interactions.
Key genes include connexins such as GJA1, GJA5, GJC1 and GJD3, adhesion genes such as CDH2, DSP, PKP2 and JUP, and vesicle-related genes such as CD9, CD63 and CD81.
Gap junctions provide low-resistance channels that allow direct ionic current flow between cells, which is required for rapid and coordinated electrical activation of the heart.
Common methods include patch clamp, dye transfer, single-cell and single-nucleus RNA-seq, spatial transcriptomics and extracellular vesicle profiling.
Heart failure, arrhythmia, dilated cardiomyopathy and hypertrophic cardiomyopathy have all been associated with altered cardiac cell communication.
Yes, single-cell studies show that fibroblasts, endothelial cells and immune cells contribute to communication networks relevant to conduction and remodeling.
Extracellular vesicles, including large blebbisomes, transfer proteins and nucleic acids between cells and can be pharmacologically modulated to protect from heart failure.
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of genes acting in cardiac cell communication.
The definition states it is any process that mediates interactions between a cell and its surroundings that contributes to the process of cardiac conduction, encompassing signaling or attachment between cells, between a cell and extracellular matrix, or between a cell and any other aspect of its environment.
Cardiomyocyte lines with CRISPR edits, primary cardiac cells, extracellular vesicle preparations and single-cell or spatial transcriptomic workflows are commonly used.

Conclusion

GO:0086065 provides a precise, ontology-based framework for studying how cardiac cells communicate with each other and with their environment to sustain conduction. The term spans gap junction channels, adhesion complexes and extracellular vesicles, and its disruption is linked to heart failure, arrhythmia and cardiomyopathy. By combining electrophysiology, single-cell and spatial omics, and vesicle biology, researchers can build mechanistic models of conduction-relevant communication. CRISPR-based knockout, point-mutation, knock-in and overexpression models are essential for converting these observations into causal insight, and EDITGENE offers the full toolkit to support such studies.

References

  1. 1. GBD 2021 Risk Factors Collaborators. 2024. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.. Lancet 403(10440):2162-2203 PMID: 38762324
  2. 2. Ping X et al.. 2025. Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m(6)A modification in atherosclerosis.. Theranostics 15(10):4785-4807 PMID: 40225569
  3. 3. Mallaredy V et al.. 2024. Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.. Circ Res 135(2):280-297 PMID: 38847080
  4. 4. He S et al.. 2025. Comprehensive analysis of scRNA-seq and bulk RNA-seq reveals the non-cardiomyocytes heterogeneity and novel cell populations in dilated cardiomyopathy.. J Transl Med 23(1):17 PMID: 39762897
  5. 6. Liu X et al.. 2023. Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics.. Cell Discov 9(1):6 PMID: 36646705
  6. 7. Jeppesen DK et al.. 2025. Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties.. Nat Cell Biol 27(3):438-448 PMID: 39984653
  7. 8. Nielsen MS et al.. 2012. Gap junctions.. Compr Physiol 2(3):1981-2035 PMID: 23723031
Contact Us
*
*
*
*
How did you hear about us: